Retail traders have been observed to be selling off their shares in the ‘Magnificent Seven’ tech stocks, with a noticeable shift towards pharmaceutical stocks, according to a recent report by JPMorgan. What Happened: Retail traders have been net sellers of the majority of the ‘Magnificent Seven’ stocks, with a focus on pharmaceuticals like Eli Lilly And Co (NYSE:LLY), JPMorgan analysts noted in a report on Wednesday, as reported by Business Insider. Over the past week, individual traders have sold off $1.4 billion worth of individual stocks, including major players like Tesla Inc (NASDAQ:TSLA)…
